Introduction
Pancreatic cancer accounts for only 2% of all newly diagnosed cancers in the USA each year, but for 5% of all cancer deaths.
1 Pancreatic cancer is resistant to conventional treatment modalities. Most pancreatic cancers are adenocarcinomas arising from the pancreatic ductal system with a frequent presence of a desmoplastic reaction around the cancer cells. In the development of pancreatic cancer, the activation of oncogenes, such as the K-ras oncogene, and a broad range of growth factors, as well as the inactivation of tumour suppressor genes, such as p53, p16 and DPC4, play an important role. 2 In particular, with a frequency of 15-70% of pancreatic cancers, the mutation of the p53 tumour suppressor gene is a major early event in pancreatic carcinogenesis.
3
Carbonic anhydrases (CAs) are zinc-containing metallo-enzymes catalysing the conversion of carbon dioxide to bicarbonate, thereby regulating the acid-base balance and respiration. 4 Moreover, CAs are involved in bone resorption, gluconeogenesis, ureagenesis and the formation of gastric acid, saliva and cerebrospinal fluid, and have been suggested to play a significant role in epithelial cell interaction and cell proliferation. 5 To date, 14 human isoforms of CA have been identified. 4 The CA IX protein (formerly called MN or G250), which was originally detected in HeLa cells,
consists of an N-terminal proteoglycan-like domain, a CA domain, a transmembrane
anchor and a C-terminal cytoplasmic tail. 6 In normal human tissue, the most prominent expression of CA IX has been reported in the mucosa of gastrointestinal organs, such as the stomach, intestine and gall-bladder. 5, 7, 8 The expression of CA IX is most abundant on the basolateral surfaces of the crypt enterocytes in the duodenum and jejunum. 8 In mouse 3T3 cells, neoplastic transformation can be induced by transfection of CA IX cDNA. 6 In addition, the over-expression of CA IX has been demonstrated in renal cell cancer, 9-12 cervical squamous cell carcinoma [13] [14] [15] and ovarian cancer, 16 among others. [17] [18] [19] [20] [21] [22] However, CA IX expression is reduced in gastric cancer. 8 The microvessel density reflects the overall degree of angiogenesis, which contributes significantly to the progression of cancer. The microvessel density is an independent prognostic indicator in several types of malignant tumours, including breast cancer, 23 ovarian cancer, 24 endometrial cancer 25 and pancreatic cancer. 26 CA IX is usually expressed in cancers with poor vascularization, and therefore the CA IX protein has been suggested to be induced by hypoxia. 15 In accordance with these findings, CA IX expression has been shown to be associated with tumours with a low microvessel density. 27 However, CA IX expression has also been found in association with high microvessel density in other cancers.
21, 28
The aims of this study were to analyse CA IX expression and CA IX inhibition in pancreatic cancer and to correlate these findings with microvessel density and p53 expression.
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Materials and methods
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Subjects
Seventy-seven patients who underwent surgical resection of the pancreas for pancreatic carcinoma were examined retrospectively. There were 43 men and 34 women. The mean age was 64 years (range, 43-81 years).
Staging was performed according to the tumour-regional lymph nodes-distant metastases (TNM) classification system as follows: there were 11 patients with pT1
tumours, 58 patients with pT2, six patients with pT3 and two patients with pT4. In 49 patients, lymph node metastases were present and, in eight patients, distant metastases.
Sixty-four carcinomas were localized in the head of the pancreas, seven carcinomas in the body and six carcinomas in the tail. Histologically, all of the carcinomas were ductal adenocarcinomas. The grading was performed in accordance with the World Health 
CA IX immunohistochemistry
For each patient, serial sections (4 µm thick) were cut from paraffin blocks, mounted on acid-cleaned glass slides and heated at 55 °C for 60 min. Sections were deparaffinized in graded alcohol and rehydrated, and the endogenous peroxidase activity was inhibited by incubation with 3% H 2 O 2 in methanol (20 min at room temperature). To reduce nonspecific background staining, slides were incubated with 5% goat serum (20 min at room temperature). Slides were incubated with the appropriate primary antibodies in a moist chamber overnight at 4 °C. The primary antibody used was monoclonal mouse anti-CA IX M75 antibody, with a dilution of 1 : 100. 30 Sections of normal human intestine were used as positive controls. For the negative control, M75 antibody was substituted with phosphate-buffered saline. The avidin-biotin peroxidase complex procedure (ABC standard; Vector Laboratoires, Burlingame, CA, USA) was then performed, and peroxidase activity was detected with diaminobenzidine as substrate.
Finally, sections were counter-stained with haematoxylin and cover-slipped with a synthetic mounting medium. The regional, cellular and sub-cellular immunohistochemical localization were evaluated for each slide by an experienced pathologist (U.K.).
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p53 immunohistochemistry
Sections were deparaffinized in a series of graded alcohols and microwaved in ethylenediaminetetra-acetic acid buffer for 2 × 10 min at 450 W. After the sections had cooled to room temperature and had been rinsed with Tris buffer, incubation was performed with anti-p53 (Do-1; Calbiochem, Cambridge, MA, USA Jump to…
Microvessel density
Microvessel density was assessed according to the methods described by a consensus conference. 33 Microvessels were visualized immunohistochemically using the monoclonal mouse immunoglobulin G anti-CD34 antibody (Biogenex, San Ramon, CA, USA), which has been shown to be a sensitive and reliable marker of microvessel density. 23 Briefly, to measure the intra-tumoral microvessel density, the stained sections were screened without any knowledge of the patient data at 50× magnification to identify the highest vascular area within the tumour. In this hot spot, the individual microvessel count was evaluated at 200× magnification using a square ocular grid. Method provided by the LightCycler software was used to estimate the concentration of each sample.
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Western blot analysis
Human pancreatic tissues were lysed in buffer containing 1 mM ethylenediaminetetraacetic acid, 50 mMβ-glycerophosphate, 2 mM sodium orthovanadate, 1% Triton-100, 10% glycerol, 1 mM dithiothreitol and protease inhibitors (10 mg/mL benzamidine, 2 mg/mL antipain and 1 mg/mL leupeptin). The lysates were homogenized and incubated on ice for 1 h, and then centrifuged at 10 000 × g and 4 °C for 15 min. The protein concentration of the supernatants was determined by the bicinchoninic acid ( CO 2 , cell cultures were pulsed for an additional 8 h with 3 H-methyl-thymidine (0.2 µCi per well). Cells were harvested on to glass fibre membranes, and the incorporated radioactivity was measured by scintillation counting. In each case, DNA synthesis was assessed six times in parallel and repeated once, resulting in 12 experiments per cell line in total.
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Statistical analysis
The correlation between CA IX immunoreactivity and patient characteristics was analysed using Fisher's exact test. The Mann-Whitney U rank sum test was used to compare CA IX and p53 immunoreactivity with microvessel density. Kruskal-Wallis analysis was used to examine the correlation between microvessel density and various clinicopathological data. All tests were two-sided, and a P value of < 0.05 was considered to be statistically significant. All analyses were performed using GraphPad InStat 3.0 (San Diego, CA, USA) software. Overall, CA IX mRNA levels were not altered in pancreatic cancer vs. adjacent normal pancreatic tissue; however, three cancers exhibited increased mRNA levels ( Figure 3 ). expression and other clinicopathological factors or patient characteristics was observed. There was no association between CA IX and p53 expression.
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Microvessel density
The mean microvessel density in the highest vascular area of pancreatic carcinoma was 5.98 vessels/mm 2 , with a range from 1.6 to 14 vessels/mm 2 ( Figure 4 ). The median microvessel density was 5.4 vessels/mm 2 . A distinction between pre-existing capillaries and newly formed microvessels induced by the tumour was not possible. For statistical evaluation, the degree of microvessel density was sub-classified as above or below the sample median. The microvessel density was independent of CA IX immunoreactivity, p53 expression, tumour stage, lymph node metastases, distance spread, histological grade, localization within the pancreas and the age and sex of the patient (Table 3 ). Acetazolamide led to a significant inhibition of cell proliferation in ASPC-1 (P = 0.03) and Panc-1 (P < 0.05) cells.
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Discussion
The expression of CA IX protein has been the subject of intense investigation in both gastrointestinal and extra-intestinal tumours. As CA IX expression has been shown to be induced by hypoxia, we analysed microvessel density in our specimens. 35 In our cohort, microvessel density did not correlate with CA IX expression or any of the clinicopathological parameters.
Interestingly, in head and neck squamous cell carcinoma and non-small-cell lung cancer, CA IX expression correlates with a higher microvessel density. 46 Based on these observations, we also treated three pancreatic cancer cell lines with acetazolamide, which resulted in the significant inhibition of cell proliferation in two of the three cell lines analysed.
In summary, we found CA IX expression to be present in a sub-group of pancreatic cancers. CA IX expression was not associated with advanced disease and was independent of p53 expression and microvessel density. We conclude that the role of CA IX is limited to a sub-group of pancreatic cancers, and may rather contribute to the early phases of pancreatic carcinogenesis. However, the growth inhibition of pancreatic cancer cells by CA inhibitors indicates that CAs may well represent interesting targets for carbo-anhydrase inhibitors in this malignancy. 
